JP5048408B2 - 臭化チオトロピウムの調製方法 - Google Patents
臭化チオトロピウムの調製方法 Download PDFInfo
- Publication number
- JP5048408B2 JP5048408B2 JP2007181381A JP2007181381A JP5048408B2 JP 5048408 B2 JP5048408 B2 JP 5048408B2 JP 2007181381 A JP2007181381 A JP 2007181381A JP 2007181381 A JP2007181381 A JP 2007181381A JP 5048408 B2 JP5048408 B2 JP 5048408B2
- Authority
- JP
- Japan
- Prior art keywords
- salt
- scopine
- mixture
- organic solvent
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 CN1C(C23C4C2*3)C4(C2)C1CC2O Chemical compound CN1C(C23C4C2*3)C4(C2)C1CC2O 0.000 description 4
- ZPHGMBGIFODUMF-UHFFFAOYSA-N OCc1ccc[s]1 Chemical compound OCc1ccc[s]1 ZPHGMBGIFODUMF-UHFFFAOYSA-N 0.000 description 2
- TUCRZHGAIRVWTI-UHFFFAOYSA-N Brc1ccc[s]1 Chemical compound Brc1ccc[s]1 TUCRZHGAIRVWTI-UHFFFAOYSA-N 0.000 description 1
- DZOKAWWIMOAPBZ-UHFFFAOYSA-N CN1C(C2)C34OC3C4CC1CC2(C#C)O Chemical compound CN1C(C2)C34OC3C4CC1CC2(C#C)O DZOKAWWIMOAPBZ-UHFFFAOYSA-N 0.000 description 1
- FIMXSEMBHGTNKT-UHFFFAOYSA-N CN1C(C2)C3OC3C1CC2O Chemical compound CN1C(C2)C3OC3C1CC2O FIMXSEMBHGTNKT-UHFFFAOYSA-N 0.000 description 1
- AFWDEHWWAREVTI-UHFFFAOYSA-N CN1C(C2)C3OC3C1CC2OC Chemical compound CN1C(C2)C3OC3C1CC2OC AFWDEHWWAREVTI-UHFFFAOYSA-N 0.000 description 1
- OYBDUZZRIYOYGY-UHFFFAOYSA-N COC(C(c1ccc[s]1)(C1=CC=CS1=C)O)=O Chemical compound COC(C(c1ccc[s]1)(C1=CC=CS1=C)O)=O OYBDUZZRIYOYGY-UHFFFAOYSA-N 0.000 description 1
- XLECSBUIYBKSEC-UHFFFAOYSA-N COC(C(c1ccc[s]1)(c1ccc[s]1)N=O)=O Chemical compound COC(C(c1ccc[s]1)(c1ccc[s]1)N=O)=O XLECSBUIYBKSEC-UHFFFAOYSA-N 0.000 description 1
- CFILUQMOMWVNPY-QRVZMLQESA-N C[C@@](C1)(C2[N](C)(C)C1C1OC21)OC(C(c1ccc[s]1)(c1ccc[s]1)O)=O Chemical compound C[C@@](C1)(C2[N](C)(C)C1C1OC21)OC(C(c1ccc[s]1)(c1ccc[s]1)O)=O CFILUQMOMWVNPY-QRVZMLQESA-N 0.000 description 1
- NUKVXVJLFCDTGJ-UHFFFAOYSA-N C[N]1(C)C(C2)C3OC3C1CC2O Chemical compound C[N]1(C)C(C2)C3OC3C1CC2O NUKVXVJLFCDTGJ-UHFFFAOYSA-N 0.000 description 1
- RJZXTEYIDXQJDH-UHFFFAOYSA-N C[N]1(C)C(C2)C3OC3C1CC2OC(C(c1ccc[s]1)(c1ccc[s]1)O)=O Chemical compound C[N]1(C)C(C2)C3OC3C1CC2OC(C(c1ccc[s]1)(c1ccc[s]1)O)=O RJZXTEYIDXQJDH-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
ある態様において、本発明は、約0.5重量%〜約40重量%の塩を含有する、式II−s
式中、Xが、Br、Cl、SO4、MeCOO、PO4、MeSO3、酒石酸、フマル酸、クエン酸、マレイン酸、コハク酸、p−トルエンスルホン酸又はアミドスルホン酸である塩を包含する。
式I
式中、Xが、Br、Cl、SO4、MeCOO、PO4、MeSO3、酒石酸、フマル酸、クエン酸、マレイン酸、コハク酸、p−トルエンスルホン酸又はアミドスルホン酸である塩を包含する。
15g(0.064mol)のスコピン臭化水素酸塩を、165mLのジメチルホルムアミド中に25℃で懸濁し、その後17.6g(0.127mol)の無水炭酸カリウムを添加し、そして該混合物を室温で約60分間撹拌した。16.2g(0.064mol)のメチルジ−(2−チエニル)−グリコレートを30mLのジメチルホルムアミド中に、4.4g(0.032mol)の無水炭酸カリウムと共に溶解し、そしてこれらを該反応混合物に約60〜65℃において添加した。該懸濁液を、真空下(70〜100mbar)で、窒素ストリッピング(2.2〜2.4L/分)下で18時間、65℃に加熱した。該反応の最後に、希DMF(「ジメチルホルムアミド」)を、該反応混合物に再導入し、そしてさらに総量15容量(225mL)について2容量のDMFを添加した。該反応混合物を0℃に冷却し、そして約168mLの2MのHBrでpH3に酸性化した(添加中の温度は20℃以下)。得られた溶液を85mLのトルエンで2回抽出し、その後、あわせた水相を0〜5℃に冷却し、そして8.5gの固形の炭酸カリウムでpH9に塩基化した。0℃で1時間後、固形物をGochP3で濾過し、そしてpH7となるように60mLの水で5回洗浄した。該固形物を真空下において45℃で16時間乾燥させ、16.5g(69%の収率、98.3%のHPLC純度)を産生した。
Claims (29)
- 前記式中、XがBrである、請求項1に記載の方法。
- 前記無機塩の含有量が、0.5重量%〜20重量%である、請求項1又は請求項2に記載の方法。
- 前記酸がHBrである、請求項1〜3のいずれか一項に記載の方法。
- さらに、前記沈殿したスコピン塩を極性有機溶媒で洗浄する工程を含んで成る、請求項1〜4のいずれか一項に記載の方法。
- 前記極性有機溶媒が、C1-6アルコール、C4-8エーテル、C3-10ケトン、C2-4ニトリル、及びこれらの混合物から成る群から選択される、請求項1〜5のいずれか一項に記載の方法。
- 前記極性有機溶媒が、メタノール、エタノール、イソプロパノール、1,4−ジオキサン、アセトン、アセトニトリル、及びこれらの混合物から成る群から選択される、請求項6に記載の方法。
- 臭化チオトロピウムを調製するための方法であって、請求項1〜7のいずれか一項に記載の方法により0.5重量%〜40重量%の無機塩を含有する式II−sのスコピン塩を調製し、そしてこれを臭化チオトロピウムに変換する工程を含んで成る、方法。
- 前記混合の前に前記スコピン塩が極性有機溶媒中で懸濁される、請求項9又は10に記載の方法。
- 前記弱無機塩基が、前記懸濁液に添加される、請求項11に記載の方法。
- 前記弱無機塩基が無水である、請求項12に記載の方法。
- 前記弱無機塩基が、8〜12のpKaを有する、請求項11〜13のいずれか一項に記載の方法。
- 前記弱無機塩基が、K2CO3、NaHCO3、Li2CO3、Cs2CO3、t−ButOK、及びt−ButOLiから成る群から選択される、請求項12に記載の方法。
- 前記弱無機塩基が、K2CO3である、請求項15に記載の方法。
- 前記弱無機塩基の添加後、前記メチル−ジ−(2−チエニル)−グリコレート及び前記弱無機塩基の他の部分を前記新たな懸濁液に添加し、混合物を供する、請求項10〜16のいずれか一項に記載の方法。
- 前記メチル−ジ−(2−チエニル)−グリコレートが、極性有機溶媒中の溶液において添加される、請求項10〜17のいずれか一項に記載の方法。
- 前記極性有機溶媒が、C1−C4アミド、C2−C4スルホキシド、C2−C4スルホン、C7−C8芳香族炭化水素、及びC2−C4ニトリルから成る群から選択される、請求項10〜18のいずれか一項に記載の方法。
- 前記極性有機溶媒が、ジメチルホルムアミドである、請求項19に記載の方法。
- 前記弱無機塩基の量が、前記スコピン塩のモル等量あたり0.45〜2.5モルである、請求項10〜20のいずれか一項に記載の方法。
- 前記弱無機塩基の添加が、25℃〜65℃の温度で行われる、請求項12〜21のいずれか一項に記載の方法。
- 前記混合物が、70℃以下の温度に加熱される、請求項22に記載の方法。
- さらに、前記N−デメチル−チオトロピウムを回収する工程を含んで成る、請求項9〜23のいずれか一項に記載の方法。
- 臭化チオトロピウムの調製方法であって、以下の工程:
a. 請求項9〜24のいずれか一項に記載の方法により、N−デメチル−チオトロピウムを調製する工程;そして
b. 有機溶媒中で該N−デメチル−チオトロピウムと臭化メチルを反応させ、臭化チオトロピウムを形成する工程、
を含んで成る方法。 - 前記有機溶媒が、C2-4ニトリル、C4-8直状若しくは環状エーテル、C2-4ニトリルとC4-8直状若しくは環状エーテルの混合物、C7-8芳香族炭化水素とC2-4ニトリルの混合物、及びC2-4ニトリルとC3-10ケトンの混合物から成る群から選択される、請求項25に記載の方法。
- 前記有機溶媒が、アセトニトリル、テトラヒドロフラン、アセトニトリルとテトラヒドロフランの混合物、トルエンとアセトニトリルの混合物及びアセトンとアセトニトリルの混合物から成る群から選択される、請求項26に記載の方法。
- 前記有機溶媒が、アセトニトリルである、請求項27に記載の方法。
- 式IIIのN−デメチルチオトロピウム又は臭化チオトロピウムの製造のための方法であって、請求項1〜7のいずれか一項に記載の方法により0.5重量%〜40重量%の無機塩を含有する式II−sのスコピン塩を調製し、そして該調製されたスコピン塩を使用する工程、を含んで成る方法。
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83023106P | 2006-07-10 | 2006-07-10 | |
US60/830,231 | 2006-07-10 | ||
US83520006P | 2006-08-03 | 2006-08-03 | |
US83520106P | 2006-08-03 | 2006-08-03 | |
US60/835,200 | 2006-08-03 | ||
US60/835,201 | 2006-08-03 | ||
US83603706P | 2006-08-07 | 2006-08-07 | |
US60/836,037 | 2006-08-07 | ||
US11/643,013 US20070167480A1 (en) | 2005-12-19 | 2006-12-19 | Pure and stable tiotropium bromide |
US11/643,013 | 2006-12-19 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012115710A Division JP5155472B2 (ja) | 2006-07-10 | 2012-05-21 | 臭化チオトロピウムの調製方法 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2008063319A JP2008063319A (ja) | 2008-03-21 |
JP2008063319A5 JP2008063319A5 (ja) | 2012-07-05 |
JP5048408B2 true JP5048408B2 (ja) | 2012-10-17 |
Family
ID=38814323
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007181381A Active JP5048408B2 (ja) | 2006-07-10 | 2007-07-10 | 臭化チオトロピウムの調製方法 |
JP2012115710A Active JP5155472B2 (ja) | 2006-07-10 | 2012-05-21 | 臭化チオトロピウムの調製方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012115710A Active JP5155472B2 (ja) | 2006-07-10 | 2012-05-21 | 臭化チオトロピウムの調製方法 |
Country Status (9)
Country | Link |
---|---|
US (1) | US20070167480A1 (ja) |
EP (1) | EP2018379B1 (ja) |
JP (2) | JP5048408B2 (ja) |
AT (1) | ATE554086T1 (ja) |
CA (1) | CA2658165A1 (ja) |
ES (1) | ES2384652T3 (ja) |
PL (1) | PL2018379T3 (ja) |
TW (1) | TW200813046A (ja) |
WO (1) | WO2008008376A2 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT106142A (pt) * | 2012-02-10 | 2013-08-12 | Hovione Farmaciencia S A | Processo para a preparação de brometo de tiotrópio |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006277968A1 (en) * | 2005-08-06 | 2007-02-15 | Boehringer Ingelheim International Gmbh | Use of tiotropium salts in the treatment of severe persistant asthma |
SI1971332T1 (sl) * | 2006-01-04 | 2011-05-31 | Boehringer Ingelheim Int | Uporaba tiotropijevih soli pri zdravljenju zmerne persistentne astme |
PL2240477T3 (pl) * | 2008-01-10 | 2015-03-31 | Generics Uk Ltd | Nowy sposób wytwarzania estrów skopiny |
US20100152224A1 (en) * | 2008-12-15 | 2010-06-17 | Auspex Pharmaceuticals, Inc. | Scopine modulators of muscarinic acetylcholine receptor |
WO2010084924A1 (ja) | 2009-01-26 | 2010-07-29 | 旭硝子株式会社 | 電子デバイス用基板の製造方法、電子デバイスの製造方法、電子デバイス用基板、および電子デバイス |
WO2011015883A1 (en) * | 2009-08-07 | 2011-02-10 | Generics [Uk] Limited | Dichloromethane solvate of tiotropium bromide and its use |
JP5822831B2 (ja) | 2009-08-07 | 2015-11-24 | ジェネリクス・[ユーケー]・リミテッド | チオトロピウム臭化物の無水物 |
WO2011095800A2 (en) * | 2010-02-02 | 2011-08-11 | Generics [Uk] Limited | Analytical methods |
TR201102068A2 (tr) * | 2011-03-03 | 2012-09-21 | Bi̇lgi̇ç Mahmut | Tiotropyum bromür içeren kristal maddeler |
CZ304368B6 (cs) * | 2011-11-28 | 2014-04-02 | Zentiva, K.S. | Směsný solvát tiotropium bromidu a způsob jeho přípravy |
CZ304808B6 (cs) | 2012-03-16 | 2014-11-05 | Zentiva, K.S. | Způsob přípravy skopinesteru kyseliny di(2-thienyl)glykolové, intermediátu v syntéze tiotropium bromidu a jeho nová forma |
CZ305012B6 (cs) | 2012-03-30 | 2015-03-25 | Zentiva, K.S. | Způsob přípravy skopinesteru kyseliny di(2-thienyl)glykolové, intermediátu v syntéze tiotropium bromidu |
CN106188012B (zh) * | 2014-06-20 | 2018-11-30 | 深圳信立泰药业股份有限公司 | 一种阿利沙坦酯结晶及其制备方法及含有该结晶的药物组合物 |
WO2019129801A1 (en) * | 2017-12-28 | 2019-07-04 | Linnea S.A. | Process for the purification of methyl-2,2-dithienylglycolate |
WO2021133280A1 (en) * | 2019-12-27 | 2021-07-01 | Deva Holding | An improved process for preparation of scopine hydrobromide |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1469781A (en) * | 1974-06-10 | 1977-04-06 | Boehringer Sohn Ingelheim | Production of scopine |
DE3211185A1 (de) * | 1982-03-26 | 1983-09-29 | Boehringer Ingelheim KG, 6507 Ingelheim | Neue quartaere 6,11-dihydro-dibenzo-(b,e)-thiepin-11-n-alkyl- norscopinether und verfahren zu deren herstellung |
DE3931041C2 (de) * | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
US5610163A (en) * | 1989-09-16 | 1997-03-11 | Boehringer Ingelheim Gmbh | Esters of thienyl carboxylic acids and amino alcohols and their quaternization products |
EP1292281B1 (de) * | 2000-10-12 | 2004-09-08 | Boehringer Ingelheim Pharma GmbH & Co.KG | Neue tiotropium-haltige inhalationspulver |
US6908928B2 (en) * | 2000-10-12 | 2005-06-21 | Bi Pharma Kg. | Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions |
DE10050995A1 (de) * | 2000-10-14 | 2002-04-18 | Boehringer Ingelheim Pharma | Neue Anticholinergika, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
DE10064816A1 (de) * | 2000-12-22 | 2002-06-27 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung eines Anticholinergikums |
US6608055B2 (en) * | 2001-06-22 | 2003-08-19 | Boehringer Ingelheim Pharma Kg | Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition |
US7358244B2 (en) * | 2003-05-28 | 2008-04-15 | Theravance, Inc. | Azabicycloalkane compounds |
EP2083007B1 (de) * | 2003-11-03 | 2013-04-24 | Boehringer Ingelheim International Gmbh | Tiotropiumsalze, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittelformulierungen |
AU2006243239A1 (en) * | 2005-05-02 | 2006-11-09 | Boehringer Ingelheim International Gmbh | Crystalline forms of tiotropium bromide |
-
2006
- 2006-12-19 US US11/643,013 patent/US20070167480A1/en not_active Abandoned
-
2007
- 2007-07-10 EP EP07810332A patent/EP2018379B1/en active Active
- 2007-07-10 CA CA002658165A patent/CA2658165A1/en not_active Abandoned
- 2007-07-10 PL PL07810332T patent/PL2018379T3/pl unknown
- 2007-07-10 JP JP2007181381A patent/JP5048408B2/ja active Active
- 2007-07-10 AT AT07810332T patent/ATE554086T1/de active
- 2007-07-10 WO PCT/US2007/015787 patent/WO2008008376A2/en active Application Filing
- 2007-07-10 ES ES07810332T patent/ES2384652T3/es active Active
- 2007-07-10 TW TW096125102A patent/TW200813046A/zh unknown
-
2012
- 2012-05-21 JP JP2012115710A patent/JP5155472B2/ja active Active
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT106142A (pt) * | 2012-02-10 | 2013-08-12 | Hovione Farmaciencia S A | Processo para a preparação de brometo de tiotrópio |
PT106142B (pt) * | 2012-02-10 | 2014-07-18 | Hovione Farmaci Ncia S A | Processo para a preparação de brometo de tiotrópio |
Also Published As
Publication number | Publication date |
---|---|
CA2658165A1 (en) | 2008-01-17 |
JP2008063319A (ja) | 2008-03-21 |
EP2018379A2 (en) | 2009-01-28 |
ES2384652T3 (es) | 2012-07-10 |
WO2008008376A3 (en) | 2008-11-13 |
WO2008008376A8 (en) | 2008-03-27 |
US20070167480A1 (en) | 2007-07-19 |
JP5155472B2 (ja) | 2013-03-06 |
EP2018379B1 (en) | 2012-04-18 |
ATE554086T1 (de) | 2012-05-15 |
TW200813046A (en) | 2008-03-16 |
PL2018379T3 (pl) | 2012-09-28 |
WO2008008376A2 (en) | 2008-01-17 |
JP2012197282A (ja) | 2012-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5048408B2 (ja) | 臭化チオトロピウムの調製方法 | |
KR100853109B1 (ko) | 항콜린제인 티오트로퓸 브로마이드의 제조방법 | |
US8344143B2 (en) | Process for the preparation of tiotropium bromide | |
US9181268B2 (en) | Anhydrate of tiotropium bromide | |
EP2121678B1 (en) | Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors | |
EP2121677B1 (en) | Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors | |
US20070135471A1 (en) | Methods for preparing irinotecan | |
US7687517B2 (en) | 3,9-Diazabicyclo [3.3.1] nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors | |
EP2552911B1 (en) | Tiotropium bromide preparation process | |
AU2014201169A1 (en) | A crystalline form of tiotropium bromide | |
MX2008003379A (en) | Process for the preparation of tiotropium bromide | |
EP2825535B1 (en) | A method of preparing the scopine ester of di-(2-thienyl)glycolic acid, an intermediate in the synthesis of tiotropium bromide, and its new form | |
JP4610333B2 (ja) | トロペノールの工業的製法 | |
WO2019086008A1 (zh) | 一种苯并三氮唑衍生物的晶型及其制备方法和用途 | |
JP2010527953A (ja) | スコピンエステルの製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110208 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110506 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110511 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110808 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120221 |
|
A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20120521 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120619 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120719 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150727 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5048408 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |